SB1317

Item number	Size	Delivery time	Price
TGM-T2653-2mg	2 mg	7 - 10 business days*	63.00€
TGM-T2653-5mg	5 mg	7 - 10 business days*	88.00€
TGM-T2653-10mg	10 mg	7 - 10 business days*	125.00€
TGM-T2653-50mg	50 mg	7 - 10 business days*	367.00€
TGM-T2653-100mg	100 mg	7 - 10 business days*	529.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase... more

Close menu

Product information "SB1317"

Description: SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3). Target: CDK, FLT, JAK. Smiles: CN1C\C=C\CCOc2cccc(c2)C2=CC=N\C(N2)=N\c2cccc(C1)c2. References: William AD, et al. Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1. 1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kina

Keywords:	TG02
Supplier:	TargetMol
Supplier-Nr:	T2653

Properties

Application:	Targets cyclin-dependent kinase 1 [EC:2.7.11.22 2.7.11.23] (CDK1, CDC2)
MW:	372.46 D
Formula:	C23H24N4O

Database Information

CAS :	1204918-72-8\| Matching products
KEGG ID :	K02087 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "SB1317"

Write a review